BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Update

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the recipient of a large drop in short interest in the month of July. As of July 31st, there was short interest totaling 60,925 shares, a drop of 42.0% from the July 15th total of 105,031 shares. Based on an average trading volume of 120,769 shares, the days-to-cover ratio is presently 0.5 days.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

A number of hedge funds have recently modified their holdings of BMEZ. Kestra Advisory Services LLC acquired a new stake in BlackRock Health Sciences Term Trust in the 4th quarter valued at about $26,000. SouthState Bank Corp purchased a new stake in BlackRock Health Sciences Term Trust in the 1st quarter valued at $29,000. PNC Financial Services Group Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust during the 1st quarter worth $35,000. Geneos Wealth Management Inc. acquired a new position in shares of BlackRock Health Sciences Term Trust during the 1st quarter valued at about $40,000. Finally, CWM LLC grew its holdings in shares of BlackRock Health Sciences Term Trust by 25.6% in the fourth quarter. CWM LLC now owns 3,336 shares of the company’s stock valued at $50,000 after purchasing an additional 680 shares during the period.

BlackRock Health Sciences Term Trust Price Performance

BMEZ opened at $16.05 on Monday. The firm’s fifty day simple moving average is $15.27 and its two-hundred day simple moving average is $14.76. BlackRock Health Sciences Term Trust has a 52-week low of $13.70 and a 52-week high of $16.25.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be given a $0.11 dividend. This represents a c) annualized dividend and a dividend yield of 8.2%. The ex-dividend date is Tuesday, September 15th.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.